Could a stem cell transplant stop immune attacks on the brain?
NCT ID NCT00716066
First seen Mar 03, 2026 · Last updated Apr 29, 2026 · Updated 9 times
Summary
This study tests a strong chemotherapy combination followed by a stem cell transplant to treat autoimmune neurologic diseases like multiple sclerosis and stiff person syndrome. The goal is to weaken the immune system so it stops attacking the nervous system. About 53 adults whose disease did not respond to standard treatments will take part. The study focuses on safety and whether the approach can control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218, United States
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
-
Swedish Medical Center-First Hill
Seattle, Washington, 98122-4307, United States
Conditions
Explore the condition pages connected to this study.